NRG > Home

| Search

Welcome to NRG Oncology!

Welcome to the NRG Oncology Web site! This resource serves to provide current information about NRG Oncology’s exciting research future and the latest updates about plans to support our clinical trial endeavors. We invite you to check back often to learn “what’s new.”

About NRG Oncology

NRG Oncology brings together the unique and complementary research areas of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG). NRG Oncology builds upon our more than 150 years of cumulative research experience to conduct practice defining, multi-institutional clinical trials resulting in the improved survival and quality of life of patients with cancer. NRG Oncology has been awarded a grant by the National Cancer Institute (NCI) as a member of the NCI National Clinical Trials Network (NCTN).

Click here to access all weekly broadcasts

NRG Oncology is proud to be an active participant of Cancer Moonshot.

Membership

Patient Advocates

Meetings

Next Semiannual Meeting July 18 - 20, 2019 - Philadelphia Marriott Downtown
NRG Future Meeting Dates
Major Scientific Meetings and Abstract Deadlines

NCORP

Learn about the leaders and plans for NRG Oncology's NCORP Research Base.

CASCADE GENETIC TESTING

Families Accelerating Cascade Testing Toolkit

NRG Oncology
Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103
267-519-6630
Contact Us

To receive the NRG Oncology Newsletter and occasional eNews announcements and press releases, please email info@nrgoncology.org

Tweets by @NRGonc

What’s New

Prophylactic Cranial Irradiation Improves Disease-Free Survival and Brain Metastasis Rates for Locally Advanced Non-Small Cell Lung Cancer Read more

NRG Oncology Trial Suggests Adding Docetaxel-based Chemotherapy to Standard Treatment Should be Considered for Men with High-Risk Prostate Cancer Read more

BAY 1895344 Project Team Member Application Read more

NRG Oncology Special Edition Newsletter on the February 2019 NRG Meeting is available Read more

NRG Oncology NCORP Pilot Projects Applications: CCDR and CPC Read more

NRG Oncology Trial Affirms Hypofractionated Radiotherapy Should Be Considered New Practice Standard for Men with Low Risk Prostate Cancer Read more

Relive the excitement from #NRG19 Read more

NRG Oncology Volume 1, 2019 is now available Read more

Due to inclement weather, the Biospecimen Banks request that you hold shipments of frozen specimens until the storms have passed. Fresh blood may be shipped as normal with extra insulation since specimens may be delayed in transit. Check fedex.com for delays and weather alerts before you ship. (posted January 17, 2019)

Special Report: NRG Oncology Strategic Planning Retreat Debrief Read more

Time to Biochemical Failure Could be Used as a Surrogate Endpoint in Treatment of Locally Advanced Prostate Cancer Read more

Project Team Member Application - Hu5F9-G4 application forms due by COB January 4, 2019. Read more

NCTN and NCORP CIRB Requirement Policy: Implementation Date Effective March 1, 2019

NOT-OD-16-094Most NRG Oncology sites are already members of the NCI CIRB but if you are not sure please contact your local IRB. Read more

NRG/RTOG Application and Server Maintenance Friday, December 7th 6:00 PM until Monday, December 10th 8:00 AM. Read more

NRG-LU002 Webinar Recording and Materials are now posted. Also, register for the follow up "Ask the PI" Question and Answer webinar. Read more

Tocagen and NRG Oncology to Collaborate on a Phase 2/3 Trial of Toca 511 & Toca FC in Newly Diagnosed Glioblastoma Read more

Hurricane Florence Notice: Potential Impact on NRG Oncology Research

MENU